Ralliant (NYSE:RAL) CEO Tamara Newcombe Sells 12,936 Shares

Ralliant Corporation (NYSE:RAL) CEO Tamara Newcombe sold 12,936 shares of the company’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ralliant Trading Down 3.5%

NYSE RAL opened at $69.42 on Wednesday. The firm has a market capitalization of $7.68 billion, a price-to-earnings ratio of -6.40, a PEG ratio of 2.69 and a beta of 1.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company’s 50 day moving average price is $68.94 and its 200 day moving average price is $55.70.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The company had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, sell-side analysts predict that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant’s dividend payout ratio is currently -1.84%.

Hedge Funds Weigh In On Ralliant

Institutional investors have recently made changes to their positions in the business. Teacher Retirement System of Texas increased its holdings in shares of Ralliant by 6.9% in the 4th quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock valued at $29,063,000 after acquiring an additional 36,800 shares during the last quarter. Irenic Capital Management LP boosted its holdings in Ralliant by 424.1% in the first quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company’s stock worth $72,376,000 after purchasing an additional 1,408,176 shares during the period. Rokos Capital Management LLP acquired a new position in Ralliant in the first quarter worth $42,022,000. California State Teachers Retirement System increased its stake in Ralliant by 23.1% during the first quarter. California State Teachers Retirement System now owns 130,822 shares of the company’s stock valued at $5,441,000 after purchasing an additional 24,591 shares during the last quarter. Finally, Fifth Third Bancorp lifted its position in shares of Ralliant by 3,988.0% in the 1st quarter. Fifth Third Bancorp now owns 32,132 shares of the company’s stock worth $1,336,000 after buying an additional 31,346 shares during the last quarter.

Analysts Set New Price Targets

RAL has been the subject of several analyst reports. Royal Bank Of Canada upped their target price on Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a research report on Friday, July 31st. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Oppenheimer lifted their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Finally, Evercore began coverage on shares of Ralliant in a report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $75.70.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.